Showing results (61-70 of 254) with videos related to

Sort By:
Pageof 26
Journal of Crohn'S & Colitis|June 4, 2025
Gene-Environment Interactions in Inflammatory Bowel Disease: A Systematic Review of Human Epidemiologic StudiesJingjing Bai, Dianne Gelien Bouwknegt, Rinse Karel Weersma, et al.
Pharmaceutics|August 28, 2019
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production ProcessBahez Gareb, Silke Posthumus, Max Beugeling, et al.
Journal of Crohn'S & Colitis|December 5, 2021
Western and Carnivorous Dietary Patterns are Associated with Greater Likelihood of IBD Development in a Large Prospective Population-based CohortVera Peters, Laura Bolte, Eva Monique Schuttert, et al.
Transplantation Direct|September 30, 2022
Luminal Preservation Protects the Small Intestine in a Brain-dead Rat ModelGuido Trentadue, Leandro Vecchio, Gursah Kats-Ugurlu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 24, 2026
STING activation promotes intestinal mucin secretion in IBDYuchen Yang, Tjasso Blokzijl, Antonio Miguel da Costa de Pina, et al.
World Journal of Gastroenterology|November 12, 2014
Performance of the Montreal classification for inflammatory bowel diseasesLieke M Spekhorst, Marijn C Visschedijk, Rudi Alberts, et al.
Nutrients|January 25, 2025
Relative Validity of the Groningen IBD Nutritional Questionnaire (GINQ-FFQ): A Food Frequency Questionnaire Designed to Assess Nutritional Intake in Patients with Inflammatory Bowel DiseaseIris Barth, Corien L Stevens, Vera Peters, et al.
The American Journal of Clinical Nutrition|January 6, 2017
Intestinal rehabilitation for children with intestinal failure is cost-effective: a simulation studyHenk Groen, Esther G Neelis, Marten J Poley, et al.
Therapeutic Drug Monitoring|April 4, 2025
Upadacitinib Optimization in a Patient With Protein-Losing Enteropathy Secondary to (Transient) Nonocclusive Mesenteric Ischemia, Idiopathic Myointimal Hyperplasia, and Hemodialysis: Grand RoundJohannes A Kroes, Michiel D Voskuil, Erin H Smeijsters, et al.
BMJ Open|November 4, 2021
Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trialMarleen Bouhuys, Willem S Lexmond, Gerard Dijkstra, et al.
Pageof 26